Literature DB >> 12643224

[Eosinophilic pneumonia caused by mesalazine. Report of one case].

Carlos Pérez1, Isabel Errázuriz, Pablo Brockmann, Sergio González, Cecilia Cofré.   

Abstract

A 50 years old male with a diagnosis of ulcerative colitis treated with mesalazine, developed after 2 months of treatment, cough, fever and progressive dyspnea. Chest X ray examination and CT scan showed pulmonary infiltrates in the right upper lobe that subsequently involved both lower lobes. A biopsy, made through videothoracoscopy, showed an eosinophilic pneumonia. After the discontinuation of mesalazine and the use of glucocorticoids, the respiratory involvement resolved, and pulmonary infiltrates regressed. Mesalazine is widely used in the treatment of inflammatory bowel diseases. Pulmonary toxicity is an uncommon complication of mesalazine treatment. Nevertheless, this complication should be considered in patients that use it and develop respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643224

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  3 in total

1.  Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Authors:  José Ferrusquía; Isabel Pérez-Martínez; Ricardo Gómez de la Torre; María Luisa Fernández-Almira; Ruth de Francisco; Luis Rodrigo; Sabino Riestra
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

2.  Granulomatous tracheo-bronchitis associated with Crohn's disease.

Authors:  Kai Xia; Jacqueline Wolf; Sonia Friedman; David L Carr-Locke
Journal:  MedGenMed       Date:  2004-02-20

3.  Tracheobronchial nodules and pulmonary infiltrates in a patient with Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Qi Zhao; Cai-Qing Zhang; Zhen-Fang Li
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.